125 related articles for article (PubMed ID: 7315192)
1. Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Soininen H; Halonen T; Riekkinen PJ
Acta Neurol Scand; 1981 Sep; 64(3):217-24. PubMed ID: 7315192
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
Nakano S; Kato T; Nakamura S; Kameyama M
J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
[TBL] [Abstract][Full Text] [Related]
5. Choline levels are increased in cerebrospinal fluid of Alzheimer patients.
Elble R; Giacobini E; Higgins C
Neurobiol Aging; 1989; 10(1):45-50. PubMed ID: 2755556
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Appleyard ME; McDonald B
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
Zubenko GS; Marquis JK; Volicer L; Direnfeld LK; Langlais PJ; Nixon RA
Biol Psychiatry; 1986 Dec; 21(14):1365-81. PubMed ID: 3024746
[TBL] [Abstract][Full Text] [Related]
10. Dementia without cholinergic deficit.
Riekkinen PJ; Soininen H; Sirviö J; Reinikainen K; Helkala EL; Paljärvi L
Gerontology; 1987; 33(3-4):268-72. PubMed ID: 3653707
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.
Elble R; Giacobini E; Scarsella GF
Arch Neurol; 1987 Apr; 44(4):403-7. PubMed ID: 3827696
[TBL] [Abstract][Full Text] [Related]
12. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
[TBL] [Abstract][Full Text] [Related]
13. [Acetylcholinesterase activity in CSF in senile dementia of Alzheimer type, vascular dementia, and Parkinson's disease].
Yoshinaga J; Sasaki T; Ideshita H; Hikiji A; Kuwaki T
Rinsho Shinkeigaku; 1989 Mar; 29(3):376-8. PubMed ID: 2752667
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-beta-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease.
Soininen H; Pitkänen A; Halonen T; Riekkinen PJ
Acta Neurol Scand; 1984 Jul; 70(1):29-34. PubMed ID: 6147948
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the course of senile dementia of the Alzheimer type using cerebrospinal fluid levels of acetylcholinesterase and somatostatin.
Urakami K; Adachi Y; Awaki E; Takahashi K
Acta Neurol Scand; 1989 Sep; 80(3):232-7. PubMed ID: 2572139
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.
Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen PJ
J Neural Transm; 1989; 75(2):119-27. PubMed ID: 2918304
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
Johansson P; Almqvist EG; Johansson JO; Mattsson N; Andreasson U; Hansson O; Wallin A; Blennow K; Zetterberg H; Svensson J
PLoS One; 2013; 8(11):e81989. PubMed ID: 24312390
[TBL] [Abstract][Full Text] [Related]
18. Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.
Sirviö J; Soininen HS; Kutvonen R; Hyttinen JM; Helkala EL; Riekkinen PJ
J Neurol Sci; 1987 Nov; 81(2-3):273-9. PubMed ID: 3694232
[TBL] [Abstract][Full Text] [Related]
19. CSF choline and acetylcholinesterase in early-onset vs. late-onset Alzheimer's disease patients.
Kumar V; Giacobini E; Markwell S
Acta Neurol Scand; 1989 Nov; 80(5):461-6. PubMed ID: 2589014
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia.
Wallin A; Sjögren M; Blennow K; Davidsson P
Dement Geriatr Cogn Disord; 2003; 16(4):200-7. PubMed ID: 14512714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
